Copyright & Intellectual Property Notice
Omnivex Technologies invests heavily in foundational breakthroughs across offline artificial intelligence, biomechanical robotics, and neuromorphic computing. This document outlines our intellectual property rights, trademarks, and restrictions on proprietary material.
LAST UPDATED: SEPTEMBER 2026 // VERSION 2.4All content on this website and within Omnivex software distributions—including but not limited to text, 3D models, computer code, interface designs, diagrams, audiovisual assets, and data schemas—is the exclusive intellectual property of Omnivex Technologies Inc. and is protected under international copyright treaties and United States, European, and Indian copyright laws.
© 2026 Omnivex Technologies Inc. All rights reserved.
The underlying architectures and system designs showcased across this platform represent confidential research, trade secrets, and pending patents held by Omnivex Technologies:
- CipherNode™: 100% air-gapped, zero-cloud local AI orchestration engine and model compilation pipeline.
- Aegis Dynamics™: Biomechanical exoskeleton kinematics, neural-to-actuator latency compression algorithms, and spatial mobility architectures.
- NeuroGenesis AI™: Bio-inspired synthetic neuromorphic topologies and sub-network pruning mechanisms.
Except as expressly authorized in writing by Omnivex Technologies Inc., you may not:
- Decompile, reverse engineer, disassemble, or derive source code or weights from Omnivex systems, shaders, or 3D assets.
- Scrape, extract, or ingest any Omnivex architectural data, diagrams, or text for training third-party artificial intelligence or machine learning models without express licensing.
- Redistribute, sublicense, mirror, or commercialize any proprietary assets or brand marks.
"Omnivex", "Omnivex Technologies", "CipherNode", "Aegis Dynamics", and "NeuroGenesis AI", along with their respective badges, logotypes, and cipher glyphs, are trademarks of Omnivex Technologies Inc. No license or right to use any trademark is conferred without prior written approval.
To request licensing agreements, academic collaboration exemptions, or reporting of copyright infringement, direct your correspondence to our legal affairs liaison: